As the methylation status of MGMT influences the survival of GBM patients mainly upon treatment with alkylating chemotherapeutic agents [13], we further analysed only the patients that received chemotherapy in addition to radiotherapy and surgery (Figure 3B). The gene discussed is MGMT; the disease is glioblastoma.